Zydus Lifesciences Ltd.

Zydus Lifesciences has received Notice of Compliance (NoC) from Health Canada for generic Liothyronine tablets 5 mcg and 25 mcg. Liothyronine tablets, a synthetic form of the thyroid hormone T3 (triiodothyronine), are primarily indicated for treating hypothyroidism.

ZDS- Liothyronine tablets will be manufactured at Zydus’ plant in Ahmedabad SEZ. Liothyronine tablets had annual sales of 10.9 mn Canadian Dollars in Canada (IQVIA MAT June 2025). 

Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.